about
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locusIdentification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategyReplication of recently identified systemic lupus erythematosus genetic associations: a case-control study.Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysisGenome-wide pathway analysis identifies VEGF pathway association with oral ulceration in systemic lupus erythematosus.Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohortsLack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus.Association of systemic lupus erythematosus clinical features with European population genetic substructure.Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritisAnalysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis.Influence of the IL6 gene in susceptibility to systemic sclerosis.2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only studyInterferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritisOverexpression of the Cytokine BAFF and Autoimmunity RiskThe systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus.SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis in anti-CCP negative Spanish rheumatoid arthritis patients.Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis.Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only studyValue of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exerciseA GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populationsPulmonary hypertension in autoimmune rheumatic diseases.Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-upNovel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosisComprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differencesIncidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review.A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosisBias in effect size of systemic lupus erythematosus susceptibility loci across Europe: a case-control study.KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factorA systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility lociInfluence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.New insight on the Xq28 association with systemic sclerosis.Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis.Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility.Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis.
P50
Q24630434-4D1632E5-A64B-4045-B9D6-B0075AFC91C2Q29417020-510DDE8A-47D5-405E-BBB3-07040A783E47Q30488972-393F91D2-E9E3-4B22-95BC-BA235214D9D2Q33766353-B35BC914-AC65-4BB2-B0F7-0240AA25B194Q33801959-7E6DDB1D-E6A2-44BE-B7FC-29FA1A32CDACQ33879759-B4DD4DB2-EB51-4398-A46E-73B50D3E556DQ33892741-DB26AD9E-9152-48B6-87B9-E1045B54ACA5Q34110676-0821306A-0983-4700-A555-2E0C29807E5AQ34128912-DE166693-E880-4406-8F8C-7B4F50BA486EQ34283946-8896C3E7-3D06-4BC1-A50D-7BB535A16B3AQ34303165-97D8A7AD-E7A9-4002-8338-869DC6781AC1Q34375158-A3203A8E-5BC0-4651-A661-C82FFE204C8CQ34438072-D781A503-761E-4396-98CD-AF44310E60B6Q34485757-43B7B136-14D8-4674-A0EA-111C2F522B36Q34555873-4CB29393-73B6-477E-9F4A-C1FA991A9E8CQ34571170-382927F8-6255-4786-AD91-D90F219F415FQ34577218-557BB2F5-AC60-4ECE-B37B-5B8B925400ABQ35035496-9BB64E73-0C25-471D-87DB-46366B8E09B7Q35178124-2A92A4C2-5ADA-46AD-8348-DA477DF62F20Q35544546-3D859D53-8B39-491A-A6CA-0669675A4B52Q35759176-0B1B6DB5-2418-4BFD-8B0F-D5EEF9DF89E2Q35784089-91155C19-C8C7-4692-8519-8D3EE98D81E9Q35816882-650F5FEB-B74A-4FEE-99F7-62233D628C9DQ35832314-AA9AADEE-CFCB-406C-B842-CADBD941BC03Q36012302-81378D46-AF06-4F7A-B5DF-8179DA9CEBA0Q36014384-DECD4ABF-7729-48ED-BB24-13B80A49AE73Q36152835-CD25AFBD-1539-482B-9CB8-5947966C5281Q36153763-A2E5E3AE-30E5-4F28-A13F-E299E7ED3EF4Q36195807-68B9B6A1-4075-4366-8639-BA53FACCAFF6Q36245847-CBDB35C8-FD1C-482F-9F7B-3D28328B081FQ36245885-6D276BCE-CD4B-4075-8BEB-ED995C39D839Q36907640-EEE83C6F-5D3B-4A9E-B8CE-67F7412A93CEQ37153818-4CAF231F-9A06-4A47-80AE-3EEB5B7C3740Q37184930-1E42EA6D-CBA3-49C5-A70F-3603B8188A90Q37282406-95A70D21-36AA-4F9E-A4F8-EA4D6D8BB844Q37441841-1BF6CB08-672E-497E-893E-2F28E286E295Q37460609-BA72C93F-FBE2-47F1-BA3A-E3B63FCF251BQ37460616-B70C1611-996A-4AE6-A8BD-7986919169EDQ37563513-CFFB9BC9-85A0-42A4-8185-22857FD76CBDQ37699878-06B53BD5-DE42-431F-87BC-CDB3445515B7
P50
description
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Patricia E Carreira
@ast
Patricia E Carreira
@en
Patricia E Carreira
@es
Patricia E Carreira
@nl
Patricia E Carreira
@sl
type
label
Patricia E Carreira
@ast
Patricia E Carreira
@en
Patricia E Carreira
@es
Patricia E Carreira
@nl
Patricia E Carreira
@sl
altLabel
patricia esmeralda carreira pe ...... carreira, patricia e. carreira
@en
prefLabel
Patricia E Carreira
@ast
Patricia E Carreira
@en
Patricia E Carreira
@es
Patricia E Carreira
@nl
Patricia E Carreira
@sl
P1053
D-4429-2018
P106
P21
P31
P3829
P496
0000-0001-8279-3806